TALPHERA, INC. Restricted Cash and Cash Equivalents
TALPHERA, INC. (TLPH) had Restricted Cash and Cash Equivalents of $178.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2019-05-09
- 2019-03-31: Restricted Cash and Cash Equivalents $178.00K.
- 2018-12-31: Restricted Cash and Cash Equivalents $178.00K.
- 2018-09-30: Restricted Cash and Cash Equivalents $178.00K.
- 2018-06-30: Restricted Cash and Cash Equivalents $178.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2019-03-31 | $178.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $178.00K 10-K · filed 2019-03-07 |
| 2018-09-30 | $178.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | $178.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $178.00K 10-Q · filed 2019-05-09 |
| 2017-12-31 | $178.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $178.00K 10-Q · filed 2018-11-05 |
| 2017-06-30 | $178.00K 10-Q · filed 2018-08-02 |
| 2017-03-31 | $178.00K 10-Q · filed 2018-05-10 |
| 2016-12-31 | $178.00K 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |